Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX9211 in diabetic peripheral neuropathic pain
NCT06203002Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Nov 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pilavapadin in diabetic polyneuropathy (DPN), sponsored by Lexicon Pharmaceuticals, Inc.. Started Nov 2023; status: completed.
02
Drugs
pilavapadin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT06203002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06203002.